Conference Short Name: Cancer 2025
Theme:Innovations, Advancements and Novel Approaches in Cancer Research & Oncology
It is a great pleasure to welcome you all at 12th International Conference on Cancer Research and Oncology, which is going to be held during December 05-06, 2025 at Dubai, UAE & Virtual (Hybrid), with a theme “Innovations, Advancements and Novel Approaches in Cancer Research & Oncology” which includes keynote presentations, speaker talks, Exhibition, Symposium, Workshops, Speaker sessions. Cancer 2025 brings together individuals who have an interest in different fields of cancer research and can attend Oncology Researchers, Doctors Scientists, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Paediatrics, Advocacy, Cancer Researchers, Cancer research Faculty, Medical Colleges, Radiologists, Chemo therapists, Pathologists, Business Entrepreneurs and Healthcare Industries.
Objectives
The prime aim of the webinar is to promote new research concept in Education and Research in all fields and disciplines of cancer research, oncology, cancer therapy, cancer treatment, on-going and future perspectives. The presence of more than 50 delegates from different countries is expected. Cancer 2025 aims to provide an opportune forum and vibrant platform for Researchers, Academicians, Scientists and Industrial Practitioners to share their ideas, original research work. This virtual conference provides an international forum for the exchange of ideas, discussions on research results and the presentation of theoretical and practical applications in these domains. The objective of this virtual conference is to create awareness and to provide a perfect platform for the participants to upgrade their knowledge and experience and to discuss on the ways to foster the exchange of concepts, prototypes, research ideas and the research work. This conference reflects the current focus of global research, recent developments, interdisciplinary research and practices in the fields of cancer research, oncology, cancer therapy, and cancer treatment, on-going and future perspectives.
“Meet Inspiring Speakers and Experts at our Scientific Meditech Conferences/Webinars with Unique Opportunity in Science, Medical and Technology field, which gives the online visibility to the Speakers, Experts and young researchers,”
Speaker Benefits at Cancer 2025
For any further information/queries, please send mail at: cancer@scientificmeditech.com; info@scientificmeditech.com;
contact@scientificmeditech.com;
11th International Conference on Cancer Research and Oncology
May 26-27, 2025 | London, UK & Virtual Meeting (Hybrid Event)
Past Conference Report: We gratefully thank all our wonderful Keynote Speakers, Chairperson, Plenary Speakers, Poster Presenter, Delegates, Students, Media Partners and Associations for making 11th International Conference on Cancer Research and Oncology, May 26-27, 2025 | London, UK & Virtual Meeting (Hybrid Event) a grand success. Scientific Meditech expresses its gratitude to the Conference Chairpersons, namely Dr. Wojciech Flieger, St. John’s Cancer Center, Department of Plastic Surgery, Poland, Italy for the support and coordinate during the sessions., Scientific Meditech would like to convey a warm gratitude and special thanks to below Keynote & Plenary Speakers of 10th International Conference on Cancer Research and Oncology, May 26-27, 2025 | London, UK & Virtual Meeting (Hybrid Event).
Dr. Wojciech Flieger, St. John’s Cancer Center, Department of Plastic Surgery, Poland
Dr. Seema Gupta, Medical School, King George’s Medical University, India
Dr. Asok Bandyopadhyay, ICT&Services Group, India
Dr. Abdus Sobhan, Alcorn State University,United States
Dr. Kent Nouri, The University of Texas MD Anderson Cancer Center. United States
Dr. Lei Huo, The University of Texas MD Anderson Cancer Center, USA
Dr. Vinoth-Kumar Lakshmanan, Sri Ramachandra Institute of Higher Education & Research, India
Dr. Chennaq Meryem, Mohammed V University in Rabat, Morocco
Dr. Changjiang Yang, Peking University People’s Hospital, China
Dr. Wahinkpe Topa, Fielding Graduate University, USA
Dr. Pu li, Tianjin Medical University, Tianjin, China
Dr. Yen-Fu Chen, Taichung Veterans General Hospital, Taiwan
Dr. Maria Antonietta Barbieri, University of Messina, Italy
Dr. Chennaq Meryem, Mohammed V University in Rabat, Morocco
Dr. Grigory Demyashkin, Sechenov First Moscow State Medical University, Russia & Many more…
With the grand success of previous editions conference. Scientific Meditech is proud to announce the "12th International Conference on Cancer Research and Oncology, which will be held during December 05-06, 2025, Dubai, UAE & Virtual (Hybrid).
Let us meet again @12th International Conference on Cancer Research and Oncology, December 05-06, 2025, Dubai, UAE & Virtual (Hybrid).
Scientific Sessions and Tracks
Session 01: Cancer Research
Session 02: Cancer Treatment, Therapies and Nursing
Session 03: Cancer Care and management
Session 04: Drug Design and Clinical Trials for Cancer
Session 05: Cancer Drugs and Vaccines
Session 06: Cancer Diagnostics and Staging
Session 07: Oncology
Session 08: Types of Cancer Therapies and applications
Session 09: Oncologists- Types and roles
Session 10: Recent Research and Innovations in Oncology
Session 11: On-going and future research in cancer treatment
Session 12: Types of Cancer and their Immunotherapy
Session 13: Oncology Biomarkers
Session 14: Breast Cancer
Session 15: Lung Cancer
Session 16: Ovarian and Cervical Cancer
Session 17: Skin Cancer
Session 18: Modern advancements in Oncology Diagnostics Technologies
Session 19: Cancer Surgery & Biopsy for cancer
Session 20: Cancer: Lifestyle and Nutrition
Session 21: Cancer diagnostic techniques
Session 22: Traditional therapy for cancer treatment
Session 23: Brain Cancer
Session 24: Case Study Reports Cancer
Session 25: Prevention and Healthy Living
Session 26: Cancer imaging test
Session 27: Cancer Pharmacology
Session 28: Pharmaceutical Oncology
Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss, and a change in bowel movements. While these symptoms may indicate cancer, they can also have other cause.
The investigation of the malignancy gene helps in targeting the mutation directly in order to treat the disease or prevent it from growth. Advanced genomic testing is helpful in recognizing the DNA variations which can cause the gene alterations resulting in the formation of cancer cells. Genomic testing help oncologists to study the about individual genomic alterations that are unique for each individual, hence preparing personalized medicine to target such mutation cells will be forever helpful in treating the disease.
The growing studies and successful researches in the field have given rise to its market value and is proceeding on its way to grab the entire market and save it from the deadly cancer disease. The global cancer genomics size was valued to be $9216 million in 2014 and grew to be $17.8 billion in 2028. The rising investments by governments in biotech, growth in the number of genomics projects, decreasing sequencing cost and the increasing R&D activities for the development of novel therapies are serving as the main pillars for the growth of the oncogenomics market.
Target Audience
Cancer 2025 brings together individuals who have an interest in different fields of cancer research and can attend Oncology Researchers, Doctors Scientists, Academic researchers, Industry specialists, Scholars in the field of Oncology, Hematology, Surgery, Nursing, Radiology, Paediatrics, Advocacy, etc Cancer Researchers, Cancer research Faculty, Medical Colleges, Radiologists, Chemo therapists, Pathologists, Business Entrepreneurs Pharmaceutical Industries, Healthcare Industries.
Opportunities for Webinar Attendees
Oral | Poster | Workshop/Symposium | e-Poster | Video Presentation |
Lung Cancer |
Leukemia |
Radiation Therapy |
Obesity |
Breast Cancer |
Liver Cancer |
Prostate Cancer |
Carcinogen |
Alcohol |
Melanoma |
Chemotherapy |
Infectious Disease |
Metastasis |
Ulcer |
Colorectal Cancer |
Mesothelioma |
Brain Tumor |
Lymphatic System |
Medical Imaging |
Skin Cancer |
Cell Division |
Disease |
Lymph |
Sunlight |
Osteosarcoma |
Pancreatic Cancer |
Cancer Screening |
Processed Meat |
Cervical Cancer |
Targeted Therapy |
Palliative Care |
Gastric Cancer |
Non-Melanoma Skin Cancer |
Radiation |
Provirus |
Carcinoma |
Oral Cancer |
Tobacco |
Benign Tumor |
Sedentary Lifestyle |
Ionizing Radiation |
Helicobacter Pylori |
Hepatitis B |
Hepatitis C |
Epstein–Barr Virus |
Cancer Staging |
Stomach Cancer |
Brain Tumors |
Kidney Cancer |
Tobacco Smoking |
Autopsy |
Immune System |
Endocrine System |
Oncogene |
Apoptosis |
Hepatocellular Carcinoma |
Bladder Cancer |
Ultraviolet Radiation |
Hormonal Therapy |
Biopsy |
Mutations |
Vaccination |
Laser Ablation |
Laser Coagulation |
Chronic Myelogenous Leukemia |
Malignancy |
Parasites |
Cachexia |
Hematuria |
Hypercalcemia |
Chemical |
Hyponatremia |
Lymphadenopathy |
Hepatomegaly |
Testicular Cancer |
Splenomegaly |
Manufacturing |
Nitrosamine |
Tumours |
Cancer Signs And Symptoms |
Anticancer |
Human Papillomavirus Infection |
Population Ageing |
Immunotherapy |
The Hallmarks Of Cancer |
Abnormal Vaginal Bleeding |
Wollastonite |
Hodgkin'S Lymphoma |
Organ Donation |
Neuroblastoma |
Retinoblastoma |
Rhabdomyosarcoma |
Carcinoid |
Carcinophobia |
Angiosarcoma |
Caner |
Cancroid |
Leiomyosarcoma |
Cancerate |
Neurofibromatosis |
Body Mass Index |
Endoscopy |
Human Papillomavirus |
Nasopharyngeal Carcinoma |
Kaposi'S Sarcoma Herpesvirus |
Kaposi'S Sarcoma |
Retrovirus |
Parenchyma |
Human T-Cell Leukemia Virus-1 |
Gastric Carcinoma |
Schistosoma Haematobium |
Liver Fluke |
Opisthorchis Viverrini |
Clonorchis Sinensis |
Germline |
Radio Frequency |
Electric Power Transmission |
Possible Carcinogen |
Intravasation |
Hereditary Cancer |
Extravasation |
Ovarian Cancer |
Hereditary Nonpolyposis Colorectal Cancer |
Carcinogens |
Cytogenetics |
Immunohistochemistry |
Cancer Immunotherapy |
Adoptive Cell Transfer |
Hormone Replacement Therapy |
Growth Hormone |
Chronic Lymphocytic Leukemia |
Cystic Fibrosis |
Lymphoblastic Leukemia |
Malignant Tumor |
Amyotrophic Lateral Sclerosis |
Malignant Melanoma |
Acute Myeloid Leukemia |
Kidney Disease |
Heart Disease |
Endometrial Cancer |
Multiple Sclerosis |
Acute Leukemia |
Lymphocytic Leukemia |
Embryonal Rhabdomyosarcoma |
Acute Lymphocytic Leukemia |
Cardiovascular Disease |
Acute Myelocytic Leukemia |
Myeloid Leukemia |
Malignant Transformation |
Tumor Suppressor Gene |
Gene Duplication |
Chromosomal Translocation |
Philadelphia Chromosome |
Microscope |
Fusion Protein |
Tyrosine Kinase |
Gene Expression |
Coding Sequence |
Tamoxifen |
Raloxifene |
Oncology |
Survival Of The Fittest |
Somatic Evolution In Cancer |
Beta-Carotene |
Tumour Heterogeneity |
Dna Methylation |
Genome Instability |
Dna Mismatch Repair |
Urinalysis |
Transmissible Cancer |
Sticker'S Sarcoma |
Bone Marrow |
Anatomical Pathology |
Cytotoxicity |
Neoplastic |
Projectional Radiography |
Small-Cell Carcinoma |
Ductal Carcinoma |
Colorectal Carcinoma |
Brachytherapy |
Squamous-Cell Carcinoma |
Birth Defects |
Immunosenescence |
Overdiagnosis |
Virotherapy |
Multi-Disciplinary |
Sexually Transmitted Infection |
Cancer Biomarker |
Bone Metastasis |
Chemotherapy Regimen |
Alkylating Antineoplastic Agent |
Combination Therapy |
Estrogen Receptor |
Bcr-Abl Tyrosine-Kinase Inhibitor |
Head And Neck Cancer |
Scientific Meditech is associated with vitalizing and refining the information about Science, Engineering, and Technology to break down the past, research display and plan another type of connected science in future.
For more details, please visit: Scientific Meditech Conferences
Scientific Meditech
61 Bridge Street
Kington HR53DJ, UK
Phone/WhatsApp: +44-1549360037
Email:
cancer@scientificmeditech.com
caroline.smith0590@gmail.com
cancerconference020@gmail.com
cancerconference021@gmail.com
cancertherapy020@gmail.com
contact@scientificmeditech.com